Sign in
4

Changes in Ownership

TuHURA Biosciences, Inc./NV Filed Acc 0001013762-16-001541

Options or other derivatives

  • Chief Financial Officer bought 3,750 shares at $8.00 ($30,000)

From the SEC's structured data for this filing

Trades in this filing

Praill Scott · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-29 Purchase : show line 1 in the form Series B Preferred Stock +3,750 $8.00 $30,000 3,750 D
Loading xslF345X03/f4042916praill_delmar.xml…